Diffusion Pharmaceuticals Inc (DFFN)

Sector:
COMMUNICATIONS
Industry:
ENTERTAINMENT
SIC:
SEMICONDUCTORS & RELATED DEVICES
CEO:
David G. Kalergis
Employees:
10
2020 AVON COURT, SUITE 4, CHARLOTTESVILLE, VA 22902
(434) 220-0718

Diffusion Pharmaceuticals, Inc. is a clinical stage company which engages in the provision of oncology-focused biotechnology. It involves in research and development, and manufacture of drug products for the treatment of cancer in combination with radiation and chemotherapy. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.

Data derived from most recent annual or quarterly report
Market Cap 29.659 Million Shares Outstanding101.92 Million Avg 30-day Volume 1.05 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.04
Price to Revenue0.0 Debt to Equity0.0 EBITDA-15.872 Million
Price to Book Value3.2648 Operating Margin0.0 Enterprise Value62.498 Million
Current Ratio7.709 EPS Growth7.027 Quick Ratio7.602
1 Yr BETA 1.3191 52-week High/Low 1.85 / 0.27 Profit Margin0.0
Operating Cash Flow Growth-37.4733 Altman Z-Score10.132 Free Cash Flow to Firm -11.524 Million
View SEC Filings from DFFN instead.

View recent insider trading info

Funds Holding DFFN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DFFN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COBUZZI ROBERT JOSEPH JR. PRESIDENT & CEO

  • Officer
  • Director
112,100 2021-11-01 2

LEVIN ALAN G

  • Director
83,300 2021-07-01 1

HOLLINGSWORTH JANE H

  • Director
83,300 2021-07-01 2

FRANCOIS ERIC

  • Director
236,000 2021-07-01 2

ADAMS ROBERT W

  • Director
83,300 2021-07-01 1

GILES MARK T

  • Director
83,300 2021-07-01 1

LANCHONEY DIANA M

  • Director
236,000 2021-07-01 2

HORNUNG WILLIAM KARL CHIEF FINANCIAL OFFICER

  • Officer
202,840 2021-03-01 1

ELDER WILLIAM ROBERT GC & SECRETARY

  • Officer
150,206 2021-03-01 1

GALLOWAY CHRISTOPHER D CHIEF MEDICAL OFFICER

  • Officer
108,717 2021-03-01 1

BYRNE THOMAS E GENERAL COUNSEL

  • Officer
0 2020-01-07 0

GAINER JOHN CHIEF SCIENTIFIC OFFICER

  • Officer
  • Director
0 2020-01-02 0

KALERGIS DAVID G CHAIRMAN AND CEO

  • Officer
  • Director
0 2020-01-02 0

RUFFOLO ROBERT R

  • Director
0 2018-06-14 0

SHEALY BEN SR VP FINANCE & TREASURER

  • Officer
0 2018-01-02 0

BLECH ISAAC

  • Director
0 2016-08-31 0

JONES DAVID RANDOLPH CHIEF MEDICAL OFFICER

  • Officer
382,557 2016-01-08 0

GILLIAM RICHARD BAXTER

  • 10% Owner
12,687,975 2016-01-08 0

WEINBERG MARK A. SR.V.P.- CLINICAL DEVELOPMENT

  • Officer
0 2014-08-04 0

SIMES STEPHEN M CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2014-07-24 0

SHERRIS DAVID CHIEF SCIENTIFIC OFFICER

  • Officer
  • Director
0 2014-07-24 0

DONENBERG PHILIP B

  • Director
0 2014-07-24 0

BARER SOL J

  • Director
0 2014-07-24 0

BRIGHT REX

  • Director
0 2014-07-24 0

STACKS NELSON K.

  • Director
0 2014-07-24 0

SCHWARTZ YAEL EXE. VP PRECLINICAL DEV.

  • Officer
  • Director
0 2014-07-24 0

BORIS TIMOTHY

  • Director
0 2014-07-24 0

ABOLIN CRAIG VP OF RESEARCH & DEV - SUBSID.

  • Officer
0 2014-06-03 0

BLECH ISAAC

LIBERTY CHARITABLE REMAINDER TRUST F/B/O ISAAC BLECH

RIVER CHARITABLE REMAINDER UNITRUST F/B/O ISAAC BLECH

WEST CHARITABLE REMAINDER UNITRUST

  • 10% Owner
185,000,000 2013-05-02 0

SCHNEIDER JOHN

  • Director
1,079,105 2012-09-13 0

SIEGEL SEYMOUR

  • Director
0 2012-08-27 0

BEARCHELL CHARLES R CHIEF ACCOUNTING OFFICER

  • Officer
0 2011-06-01 0

RUBINSTEIN JEROLD H

  • Director
900,000 2011-05-24 0

BLECH ISAAC

LIBERTY CHARITABLE REMAINDER TRUST F/B/O ISAAC BLECH

WEST CHARITABLE REMAINDER UNITRUST

BLECH MIRIAM

  • 10% Owner
0 2011-05-24 0

FELLER PAUL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
  • 10% Owner
26,238,427 2010-04-14 0

DUNLEAVY MIKE SR.

  • Director
5,000 2009-10-15 0

GOLENBERG GLENN

  • Director
178,000 2009-04-30 0

CROSS RANDALL

  • Director
0 2009-04-30 0

FELLER RALPH

  • 10% Owner
9,329,655 2008-03-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 22:15:04 UTC -2.8496 2.9196 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 21:45:03 UTC -2.8496 2.9196 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 21:15:03 UTC -2.8496 2.9196 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 20:45:03 UTC -2.579 2.649 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 20:15:04 UTC -2.579 2.649 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 19:45:03 UTC -2.579 2.649 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 19:15:03 UTC -2.579 2.649 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 18:45:03 UTC -2.579 2.649 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 18:15:03 UTC -2.579 2.649 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 17:45:03 UTC -2.579 2.649 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 17:15:03 UTC -2.579 2.649 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 16:45:03 UTC -2.579 2.649 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 16:15:04 UTC -2.579 2.649 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 15:45:03 UTC -2.579 2.649 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 15:15:03 UTC -2.579 2.649 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 14:45:03 UTC -3.8082 3.8782 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 14:15:03 UTC -3.8082 3.8782 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 13:45:03 UTC -3.8082 3.8782 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 13:15:03 UTC -3.8082 3.8782 2400000
DIFFUSION PHARMACEUTICALS IN DFFN 2022-01-17 12:45:03 UTC -3.8082 3.8782 2400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund DFFN -14400.0 shares, $-7339.68 2021-09-30 N-PORT

Elevate your investments